Home > Annual Financials > UNICHEM LABORATORIES

UNICHEM LABORATORIES Financial Statement Analysis
[BOM: 506690|NSE : UNICHEMLAB]

The Revenues of UNICHEM LABORATORIES have decreased by -98.67% YoY .
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has increased by Positive YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

UNICHEM LABORATORIES Last 5 Annual Financial Results
[BOM: 506690|NSE : UNICHEMLAB]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹1,785 Cr₹134,302 Cr₹1,270 Cr₹1,235 Cr₹1,104 Cr
Expenses ₹1,698 Cr₹138,858 Cr₹1,197 Cr₹1,144 Cr₹1,155 Cr
Operating Profit (Excl OI) ₹87 Cr₹-4,556 Cr₹73 Cr₹91 Cr₹-51 Cr
Other Income ₹32 Cr₹3,852 Cr₹48 Cr₹50 Cr₹91 Cr
Interest ₹23 Cr₹1,731 Cr₹6.11 Cr₹5.12 Cr₹7.85 Cr
Depreciation ₹123 Cr₹11,344 Cr₹91 Cr₹84 Cr₹82 Cr
Profit Before Tax ₹-85 Cr₹-17,636 Cr₹22 Cr₹51 Cr₹-48 Cr
Profit After Tax ₹-94 Cr₹-20,223 Cr₹33 Cr₹34 Cr₹-60 Cr
Consolidated Net Profit ₹-94 Cr₹-20,223 Cr₹33 Cr₹34 Cr₹-60 Cr
Earnings Per Share (Rs)₹19.53₹-13.32₹-28.72₹4.70₹4.88
PAT Margin (%)6.51-5.25-15.062.602.78
ROE(%)5.64-3.86-8.041.281.35
ROCE(%)6.34-2.31-5.601.002.11
Total Debt/Equity(x)0.180.090.120.130.04

Key Financials

Market Cap : ₹ 4,157.5 Cr
Revenue (TTM) : ₹ 2,028.9 Cr
Net Profit(TTM) : ₹ 150.6 Cr
EPS (TTM) : ₹ 21.4
P/E (TTM) : 27.6

Industry Peers & Returns1W1M1Y
UNICHEM LABORATORIES -1.8% -6.1% 11.7%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -0.9% 4.8%
DIVIS LABORATORIES -0.7% 1.6% 50.2%
CIPLA -1.7% -1.1% -2.3%
TORRENT PHARMACEUTICALS -1.1% 1.6% 13.7%
DR REDDYS LABORATORIES -4.3% -8% -4.4%
MANKIND PHARMA 6.8% 8% 20.9%
ZYDUS LIFESCIENCES -1.9% 0.1% -16.5%
LUPIN -4.3% -6.4% 4.6%


UNICHEM LABORATORIES Revenues
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

-98.67 %

5 Yr CAGR

12.77 %

Years Revenues % Change
Mar2025 ₹1,785 Cr
-98.67
Mar2024 ₹134,302 Cr
10,476.38
Mar2023 ₹1,270 Cr
2.81
Mar2022 ₹1,235 Cr
11.91
Mar2021 ₹1,104 Cr -


UNICHEM LABORATORIES Operating Profit
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Positive

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2025 ₹87 Cr
Positive
Mar2024 ₹-4,556 Cr
Negative
Mar2023 ₹73 Cr
-20.10
Mar2022 ₹91 Cr
Positive
Mar2021 ₹-51 Cr -

Operating Margins
Y-o-Y

Positive

5 Yr CAGR

Positive

Years Operating Margin% % Change
Mar2025 4.87%
Positive
Mar2024 -3.39%
Negative
Mar2023 5.73%
-22.36
Mar2022 7.38%
Positive
Mar2021 -4.6% -

UNICHEM LABORATORIES Profit After Tax
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2025 ₹-94 Cr
Negative
Mar2024 ₹-20,223 Cr
Negative
Mar2023 ₹33 Cr
-3.68
Mar2022 ₹34 Cr
Positive
Mar2021 ₹-60 Cr -

PAT Margins
Y-o-Y

Positive

5 Yr CAGR

23.70 %

Years PAT Margin(%) % Change
Mar2025 6.51 %
Positive
Mar2024 -5.25 %
Negative
Mar2023 -15.06 %
Negative
Mar2022 2.6 %
-6.47
Mar2021 2.78 % -

UNICHEM LABORATORIES Earnings Per Share (EPS)
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Positive

5 Yr CAGR

41.44 %

Years EPS % Change
Mar2025 ₹20
Positive
Mar2024 ₹-13
Negative
Mar2023 ₹-29
Negative
Mar2022 ₹4.70
-3.69
Mar2021 ₹4.88 -

UNICHEM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 506690|NSE : UNICHEMLAB]

Y-o-Y

Positive

5 Yr CAGR

31.66 %

Years ROCE % Change
Mar2025 6.34%
Positive
Mar2024 -2.31%
Negative
Mar2023 -5.6%
Negative
Mar2022 1%
-52.61
Mar2021 2.11% -

UNICHEM LABORATORIES Share Price vs Sensex

Current Share Price : ₹590.6
Current MarketCap: ₹ 4,157.5 Cr
Updated EOD on :Jul 11,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
UNICHEM LABORATORIES

-1.8%

-6.1%

11.7%

SENSEX

-1.1%

-0%

3.2%

UNICHEM LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP -0.6% 0.4% 0.8%
BSE HEALTHCARE -1.3% 0.7% 16.5%
No NSE index found

You may also like the below Video Courses


FAQ about UNICHEM LABORATORIES Financials


How the annual revenues of UNICHEM LABORATORIES have changed ?

The Revenues of UNICHEM LABORATORIES have decreased by -98.67% YoY .

How the Earnings per Share (EPS) of UNICHEM LABORATORIES have changed?

The Earnings Per Share (EPS) of UNICHEM LABORATORIES has increased by Positive YoY .